Curocell Inc. (KOSDAQ: 372320)

Market Cap	430.45B
Revenue	n/a
Net Income	n/a
Shares Out	14.11M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	264,392
Open	29,950
Previous Close	31,250
Day's Range	29,450 - 30,850
52-Week Range	19,390 - 43,000
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Apr 3, 2025

About Curocell

Curocell Inc. develops CAR-T cell therapy for the treatment of cancer. It focuses on the development of CD19 CAR-T for the treatment of lymphoma; and BCMA CAR-T for the treatment of multiple myeloma. The company was incorporated in 2016 and is based in Daejeon, South Korea.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 2016
• Country: South Korea
• Stock Exchange: KOSDAQ
• Ticker Symbol: 372320